Clinical Trial: Screening for non-alcoholic fatty liver disease and intervention therapy with growth hormone in adult patients with pituitary stalk interruption syndrome (PSIS) (China)

China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Screening for non-alcoholic fatty liver disease and intervention therapy with growth hormone in adult patients with pituitary stalk interruption syndrome (PSIS)'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135816

Registration Time: 2026/11/02

Type: Interventional study

Primary Sponsor: The First Medical Center, Chinese PLA General Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342728

Published by HT Digital Content Services with permission from Health Daily Digest....